2023
DOI: 10.3389/fphys.2023.1207003
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Hibernation and hemostasis

Abstract: Hibernating mammals have developed many physiological adaptations to accommodate their decreased metabolism, body temperature, heart rate and prolonged immobility without suffering organ injury. During hibernation, the animals must suppress blood clotting to survive prolonged periods of immobility and decreased blood flow that could otherwise lead to the formation of potentially lethal clots. Conversely, upon arousal hibernators must be able to quickly restore normal clotting activity to avoid bleeding. Studie… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
13
7
2
0

Citation Types

0
13
0
0

Year Published

Range
2024
2024
2026
2026

Publication Types

Select...
16
3
2

Relationship

0
21

Authors

Journals

citations

Cited by 21 publications

(13 citation statements)
references

References 96 publications

0
13
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…We highlight that microthrombosis, NETs, and myeloperoxidase-positive cells were absent in our study; on the other hand, in COVID-19 patients, activated platelets can release vasoactive, haemostatic, and inflammatory mediators, triggering the coagulation cascade, providing a procoagulant surface for secondary haemostasis and, additionally, inducing the release of neutrophil extracellular traps [ 58 ]. The resistance to pulmonary microthrombosis observed may be explained by the species-specific mechanism of clot breakdown observed in hamsters during cold-stress hibernation [ 59 ]. In our hypothesis, this efficient mechanism of clot breakdown should be studied further until it is well understood since it could be a method of coagulopathy prevention in COVID-19 patients.…”
Section: Discussion
mentioning
confidence: 99%